Clinical trial · Observational
Multiple Myeloma Turkish Prospective Patient Registry
Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study
NCT04143932CI-TRIAL-00068052THD-MM-RegunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
| Relapse Multiple Myeloma | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Overall Survival
- timeFrame
- [Time Frame: 5 Years]
- description
- Time from the diagnosis to the death
- measure
- Progression Free Survival
- timeFrame
- [Time Frame: 5 Years]
- description
- Time from the initiation of treatment to the death from any cause or progression
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed as multiple myeloma * Patients signed informed consent form * Patients received no more then 2 lines of therapy Exclusion Criteria: * Patients below 18 years old
References
Publications (0)
Data not yet available
No reference posted for this study.